Central Nervous System Stimulant international drug patents, generic suppliers and generics

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-005	Dec 10, 2007		RX	Yes	No	➤ Sign Up	➤ Sign Up		Y		➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-005	Dec 10, 2007		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-006	Dec 10, 2007		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-003	Feb 23, 2007		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Shire Dev Llc	VYVANSE	lisdexamfetamine dimesylate	TABLET, CHEWABLE;ORAL	208510-006	Jan 28, 2017		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Shire Development	VYVANSE	lisdexamfetamine dimesylate	CAPSULE;ORAL	021977-004	Dec 10, 2007		RX	Yes	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Central Nervous System Stimulant Drug Class List